Xenon Pharmaceuticals, Inc. (XENE)

40.88 -0.35 (-0.85%) USD  |  NASDAQ  |  Jan 13, 09:58
More

Xenon Pharmaceuticals Underperform Recommendations

Underperform Recommendations Chart

View Underperform Recommendations for XENE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Underperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Underperform Recommendations Range, Past 5 Years

View Underperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Underperform Recommendations Benchmarks

View Underperform Recommendations Benchmarks
Start Trial
Oncolytics Biotech, Inc. Upgrade
Aurinia Pharmaceuticals, Inc. Upgrade
Edesa Biotech, Inc. Upgrade
Lexaria Bioscience Corp. Upgrade
ProMIS Neurosciences, Inc. Upgrade